Bortezomib at therapeutic doses poorly passes the...

Brain Communications 2020 / 01 Vol. 2; Iss. 1

Bortezomib at therapeutic doses poorly passes the blood–brain barrier and does not impair cognition

Huehnchen, Petra, Springer, Andreas, Kern, Johannes, Kopp, Ute, Kohler, Siegfried, Alexander, Tobias, Hiepe, Falk, Meisel, Andreas, Boehmerle, Wolfgang, Endres, Matthias
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
2
Journal:
Brain Communications
DOI:
10.1093/braincomms/fcaa021
Date:
January, 2020
File:
PDF, 562 KB
2020
Conversion to is in progress
Conversion to is failed